Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease

Journal of Neurochemistry

Volumn 121, Issue 4, 2012, Pages 639-648

  Anglada Huguet, Marta ^a,b,c   Giralt, Albert ^a,b,c   Perez Navarro, Esther ^a,b,c   Alberch, Jordi ^a,b,c   Xifró, Xavier ^a,b,c,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITY OF GIRONA   (Spain)

Author keywords

Huntingtin; Immediate early genes; Knock in cells; Neuroprotection; R6 mouse; Transcription

Indexed keywords

CASPASE 3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; EXON; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUNTINGTON CHOREA; MALE; MOUSE; MUTANT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; APOPTOSIS; BIOTRANSFORMATION; BLOTTING, WESTERN; CELL NUCLEUS; CORPUS STRIATUM; CYTOSOL; DISEASE PROGRESSION; EARLY GROWTH RESPONSE PROTEIN 2; ETS-DOMAIN PROTEIN ELK-1; GENES, FOS; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MUTATION; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBCELLULAR FRACTIONS; TRANSFECTION;

MUS;

EID: 84859785962     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07711.x     Document Type: Article

References (50)

1. Apostol B. L., Illes K., Pallos J. et al. (2006) Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity. Hum. Mol. Genet. 15, 273-285. (Pubitemid 43125981)
2. Besnard A., Galan-Rodriguez B., Vanhoutte P. and Caboche J. (2011) Elk-1 a transcription factor with multiple facets in the brain . Front. Neurosci. 5, 35.
3. Boros J., O'Donnell A., Donaldson I. J., Kasza A., Zeef L. and Sharrocks A. D. (2009) Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factors family members. Nucleic Acids Res. 37, 7368-7380.
4. Buchwalter G., Gross C. and Wasylyk B. (2004) Ets ternary complex transcription factors. Gene 324, 1-14. (Pubitemid 38030321)
5. Canals J. M., Checa N., Marco S., Akerud P., Michels A., Pérez-Navarro E., Tolosa E., Arenas E. and Alberch J. (2001) Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. J. Neurosci. 21, 117-124. (Pubitemid 32098733)
6. Demir O., Aysit N., Onder Z., Turkel N., Ozturk G., Sharrocks A. D. and Kurnaz I. A. (2011) ETS-domain transcription factor Elk-1 mediates neuronal survival: SMN as a potential target. Biochem. Biophys. Acta 1812, 652-662.
7. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993. (Pubitemid 27449140)
8. Ferrer I., Blanco R. and Carmona M. (2001) Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat. Brain Res. Mol. Brain Res. 94, 48-58. (Pubitemid 32964745)
9. Gianfriddo M., Melani A., Turchi D., Giovannini M. G. and Pedata F. (2004) Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol. Dis. 17, 77-88. (Pubitemid 39209315)
10. Gille H., Strahl T. and Shaw P. E. (1995a) Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5, 1191-1200.
11. Gille H., Kortenjann M., Thomae O., Moomaw C., Slaughter C., Cobb M. H. and Shaw P. E. (1995b) ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14, 951-962.
12. Gines S., Ivanova E., Seong I. S., Saura C. A. and MacDonald M. E. (2003) Enhanced Akt signalling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J. Biol. Chem. 278, 50514-50522. (Pubitemid 37548897)
13. Gineaposs S., Paoletti P. and Alberch J. (2010) Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression. J. Biol. Chem. 285, 21537-21548.
14. Giralt A., Rodrigo T., Martín E. D., Gonzalez J. R., Milà M., Ceña V., Dierssen M., Canals J. M. and Alberch J. (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 158, 1234-1250.
15. Gokce O., Runne H., Kuhn A. and Luthi-Carter R. (2009) Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation. PLoS ONE 4, e5292.
16. Janknecht R., Ernst W. H., Pingoud V. and Nordheim A. (1993) Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12, 5097-5104. (Pubitemid 23358499)
17. Knapska E. and Kaczmarek L. (2004) A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? . Prog. Neurobiol. 74, 183-211. (Pubitemid 39535508)
18. Lawson V. J., Weston K. and Maurice D. (2010) Early growth response 2 regulates the survival of thymopcytes during positive selection. Eur. J. Immunol. 40, 232-241.
19. Li S. H. and Li X. J. (2004) Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20, 146-154.
20. Liu Y. F. (1998) Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line. J. Biol. Chem. 273, 28873-28877.
21. Luthi-Carter R., Strand A., Peters N. L. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 1259-1271. (Pubitemid 30312475)
22. Luthi-Carter R., Hanson S. A., Strand A. D. et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 11, 1911-1926.
23. Mangiarini L., Sathasivam K., Seller M. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506. (Pubitemid 26374323)
24. Nijhawan D., Fang M., Traer E., Zhong Q., Gao W., Du F. and Wang X. (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17, 1475-1486. (Pubitemid 36734705)
25. Nucifora F. C., Jr, Sasaki M., Peters M. F. et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428. (Pubitemid 32231807)
26. Perrin V., Dufour N., Raoul C., Hassig R., Brouillet E., Aebischer P., Luthi-Carter R. and Deaposglon N. (2009) Implication of the JNK pathway in a rat model of Huntington's disease. Exp. Neurol. 215, 191-200.
27. Price M. A., Rogers A. E. and Treisman R. (1995) Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J. 14, 2589-2601.
28. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B. and Young A. B. (1988) Differencial loss of striatal projection neurons in Huntington disease. Proc Natl Acad. Sci. USA 85, 5733-5737.
29. Roze E., Betuing S., Deyts C., Marcon E., Brami-Cherrier K., Pagès C., Humbert S., Mérienne K. and Caboche J. (2008) Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin- induced transcriptional dysregulation and striatal death. FASEB J. 22, 1083-1093. (Pubitemid 351519963)
30. Saavedra A., Giralt A., Rue L., Xifró X., Xu J., Ortega Z., Lucas J. J., Lombroso P. J., Alberch J. and Perez-Navarro E. (2011) STriatal- Enriched protein tyrosine Phosphatase expression and activity in Huntington's disease - a STEP in the resistance to excitotoxicity. J. Neurosci. 31, 8150-8162.
31. Sgambato V., Vanhoutte P., Pagès C., Rogard M., Hipskind R., Besson M. J. and Caboche J. (1998a) In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J. Neurosci. 18, 214-226. (Pubitemid 28046783)
32. Sgambato V., Pagès C., Rogard M., Besson M. J. and Caboche J. (1998b) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 8814-8825. (Pubitemid 28491747)
33. Sharma A., Callahan L. M., Sul J. Y., Kim T. K., Barrett L., Kim M., Powers J. M., Federoff H. and Eberwine J. (2010) A neurotoxic phosphoform of Elk-1 associates with inclusions from multiple neurodegenerative diseases. PLoS ONE 5, e9002.
34. Sharrocks A. D. (2002) Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF (ternary complex factor) subfamily. The Colworth Medal Lecture. Biochem. Soc. Trans. 30, 1-9.
35. Sharrocks A. D., Yang S. H. and Galanis A. (2000) Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25, 448-453. (Pubitemid 30662413)
36. Shaw P. E. and Saxton J. (2003) Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 35, 1210-1226. (Pubitemid 36577311)
37. Shore P. and Sharrocks A. D. (1995) The ETS-domain transcription factors Elk-1 and SAP-1 exhibit differential DNA binding specificities. Nucleic Acids Res. 23, 4698-4706. (Pubitemid 126003274)
38. Spektor B. S., Miller D. W., Hollingsworth Z. R., Kaneko Y. A., Solano S. M., Johnson J. M., Penney J. B., Jr, Young A. B. and Luthi-Carter R. (2002) Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease. Brain Res. Mol. Brain Res. 102, 118-128. (Pubitemid 34607750)
39. Steffan J. S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y. Z., Gohler H., Wanker E. E., Bates G. P., Housman D. E. and Thompson L. M. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. U S A 97, 6763-6768. (Pubitemid 30412788)
40. Sugimoto T., Stewart S. and Guan K. L. (1997) The calcium/calmodulin- dependent protein phosphatase calcineurin is the major Elk-1 phosphatase. J. Biol. Chem. 272, 29415-29418. (Pubitemid 27508020)
41. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
42. Tian J. and Karin M. (1999) Stimulation of Elk1 transcriptional activity by mitogen-activated protein kinases is negatively regulated by protein phosphatase 2B (calcineurin). J. Biol. Chem. 274, 15173-15180.
43. Treisman R. (1995) Journey to the surface of the cell: Fosregulation and the SRE. EMBO J. 14, 4905-4913.
44. Vanhoutte P., Barnier J. V., Guibert B., Pagès C., Besson M. J., Hipskind R. A. and Caboche J. (1999) Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol. Cell. Biol. 19, 136-146. (Pubitemid 29018416)
45. Vonsattel J. P. and DiFiglia M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384. (Pubitemid 28237321)
46. Wartiovaara K., Barnabe-Heider F., Miller F. D. and Kaplan D. R. (2002) N-myc promotes survival and induce S-phase entry of postmitotic sympathetic neurons. J. Neurosci. 22, 815-824. (Pubitemid 34141762)
47. Wasylyk B., Hagman J. and Gutierrez-Hartmann A. (1998) Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 23, 213-216. (Pubitemid 28302618)
48. Xifró X., García-Martínez J. M., Del Toro D., Alberch J. and Pérez- Navarro E. (2008) Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells. J. Neurochem. 105, 1596-1612.
49. Xifró X., Giralt A., Saavedra A., García-Martinez J. M., Díaz-Hernandez M., Lucas J. J., Alberch J. and Pérez-Navarro E. (2009) Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity. Neurobiol. Dis. 36, 461-469.
50. Xifró X., Anglada-Huguet M., Rue L., Saavedra A., Perez-Navarro E. and Alberch J. (2011) Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity. Mol. Neurodegener. 6, 74.